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ARTICLE
Candidalysin activates innate epithelial immune
responses via epidermal growth factor receptor
Jemima Ho1, Xuexin Yang 1, Spyridoula-Angeliki Nikou1,10, Nessim Kichik1,2, Andrew Donkin1, Nicole O. Ponde1,
Jonathan P. Richardson1, Remi L. Gratacap3,11, Linda S. Archambault3, Christian P. Zwirner3, Celia Murciano1,12,
Rhonda Henley-Smith4, Selvam Thavaraj 4, Christopher J. Tynan 5, Sarah L. Gaffen6, Bernhard Hube7,8,
Robert T. Wheeler 3,9, David L. Moyes1 & Julian R. Naglik 1
Candida albicans is a fungal pathobiont, able to cause epithelial cell damage and immune
activation. These functions have been attributed to its secreted toxin, candidalysin, though
the molecular mechanisms are poorly understood. Here, we identify epidermal growth factor
receptor (EGFR) as a critical component of candidalysin-triggered immune responses. We
find that both C. albicans and candidalysin activate human epithelial EGFR receptors and
candidalysin-deficient fungal mutants poorly induce EGFR phosphorylation during murine
oropharyngeal candidiasis. Furthermore, inhibition of EGFR impairs candidalysin-triggered
MAPK signalling and release of neutrophil activating chemokines in vitro, and diminishes
neutrophil recruitment, causing significant mortality in an EGFR-inhibited zebrafish swim-
bladder model of infection. Investigation into the mechanism of EGFR activation revealed the
requirement of matrix metalloproteinases (MMPs), EGFR ligands and calcium. We thus
identify a PAMP-independent mechanism of immune stimulation and highlight candidalysin
and EGFR signalling components as potential targets for prophylactic and therapeutic
intervention of mucosal candidiasis.
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C andida albicans is a fungus commonly present in thehealthy microbiota of oral, gut and vaginal mucosae.Infections with this species can be superficial or systemic
and are particularly common in immunocompromised patients,
where significant morbidity and mortality is attributed1. A
defining feature of C. albicans pathogenesis is the generation of
filamentous hyphae. Hyphae damage mucosal epithelia and
induce immune activation. In a recent study we identified can-
didalysin, a cytolytic peptide toxin secreted by C. albicans hyphae
that accounts for both the epithelial damage and immunosti-
mulatory capacity of this fungus2. Candidalysin is generated from
its parent protein (Ece1p) via sequential enzymatic processing by
fungal kexin enzymes and secreted from hyphae3. In oral and
vaginal epithelial cells, candidalysin induces the release of lactate
dehydrogenase (LDH)2,4, indicative of cell damage and mem-
brane destabilisation. Candidalysin activates epithelial immunity
via mitogen-activated protein kinase (MAPK) signalling mole-
cules, namely c-Fos transcription factor and MAPK phosphatase
1 (MKP1)2,5,6. MAPK signalling constitutes a “danger-response”
pathway7–9 which induces neutrophil recruitment and innate
Type-17 immunity, critical for protection against mucosal
candidiasis2,4,10,11. The mechanism of candidalysin detection by
epithelial cells is unknown.
The epidermal growth factor receptor (EGFR or ErbB1/Her1)
is a membrane-bound tyrosine kinase, which, together with,
ErbB2 (Her2), ErbB3 (Her3) and ErbB4 (Her4), constitute the
ErbB family12. The distribution of EGFR is diverse throughout
the body and receptor activation can trigger signalling via several
major pathways, including MAPK, phosphoinositide 3 kinase
(PI3K), nuclear factor kappa light chain enhancer of activated B
cells (NF-ĸB) and janus kinase/signal transducer and activator of
transcription (JAK/STAT) pathways13–15. EGFR signalling can
result in a number of outcomes primarily associated with growth,
including cell proliferation, survival, angiogenesis, adhesion, dif-
ferentiation and motility. A wide variety of viruses and bacteria
are known to exploit EGFR functions for infectious and replica-
tive benefit. However, EGFR also functions to protect the host
during disease16–19 and can contribute to the maintenance of
epithelial barriers and defences16,20.
We now document the EGFR as a critical component of
candidalysin-triggered immune responses at the epithelium and
identify a protective role for EGFR during C. albicans infection.
We demonstrate that EGFR is activated by both C. albicans and
candidalysin, with candidalysin-deficient fungi exhibiting
impaired ability to induce EGFR phosphorylation during murine
oropharyngeal candidiasis (OPC). In vitro use of EGFR kinase
inhibitors (including FDA approved Gefitinib) block C. albicans
and candidalysin-induced MAPK signalling and secretion of
neutrophil activating cytokines. Accordingly, suppressed neu-
trophil recruitment and significant mortality in a zebrafish
swimbladder model of infection is also observed following EGFR
inhibition. Investigation into the mechanism of EGFR activation
during infection revealed the contribution of EGFR ligands,
MMPs and calcium flux as key drivers of EGFR signalling and
immune stimulation.
Herein, we identify a mechanism of candidalysin-triggered
EGFR activation and signalling, which initiates early epithelial cell
responses during C. albicans infection. As such, we highlight
EGFR and its related signalling molecules as potential targets for
therapeutic intervention against Candida infection.
Results
EGFR is activated by C. albicans and candidalysin. To identify a
potential host receptor for candidalysin, we first investigated the
involvement of well-documented pattern recognition receptors
(PRRs) and their adapters in TR146 human oral epithelial cells.
siRNA-mediated knockdown of dectin-1, dectin-2, mincle,
MyD88, TRIF, TRAM, MAL, TRAF6, DC-SIGN, NOD1, NOD2,
TLR1 or TLR6 had no significant effect on the ability of C.
albicans to induce c-Fos expression or MKP1 phosphorylation at
2 h post infection (p.i.) (previously determined to be the optimal
time for activation2,21), indicating their collective lack of invol-
vement in the candidalysin response pathway (Supplementary
Fig. 1). Additionally, siRNA knockdown of TLR2 and TLR4 was
previously documented to have no effect on C. albicans-induced
c-Fos activation or MKP1 phosphorylation21.
Next, we utilised previously published transcription array
datasets of C. albicans-infected TR146 cells to identify possible
pathways activated by candidalysin22. Ontologocial analysis of
differentially expressed genes showed that EGFR binding was the
third most significantly different ontology within the molecular
function and biological processes categories. Further, functional
annotation clustering of all ontology profiles using database for
annotation, Visualisation and Integrated Discovery (DAVID),
indicated the most significant cluster incorporated extensive
EGFR/ErbB-associated gene sets, networks and pathways (Sup-
plementary Fig. 2). Accordingly, we demonstrated that EGFR (but
not phospho-sites of other ErbB family members (Supplementary
Fig. 3)), is phosphorylated. This is observed at two distinct
tyrosine sites, Y1068 and Y845, following C. albicans infection
(Fig. 1a, left panel) or candidalysin treatment in a dose-dependent
manner (Fig. 1a, right panel). Additionally, a C. albicans mutant
strain deficient in the candidalysin-encoding region (ece1Δ/Δ
+ECE1Δ184–279) was poorly able to induce EGFR phosphorylation
at either tyrosine site (Fig. 1a, left panel). In light of these
findings, we assessed the TR146 cell line for EGFR mutations to
rule out potential genetic predisposition towards these observa-
tions. No EGFR mutations were found (Supplementary Fig. 4).
Given that EGFR is internalised upon activation, we used
Imagestream X analysis, combining in-built fluorescent imaging
and flow cytometry, to measure EGFR internalisation following
candidalysin exposure. At 30 min post candidalysin treatment, a
statistically significant increase in internalised cytoplasmic EGFR
was observed (Fig. 1b). Furthermore, in a murine model of
oropharyngeal candidiasis (OPC), a C. albicans strain lacking the
candidalysin parent gene ECE1 (ece1Δ/Δ) or candidalysin-
encoding region (ece1Δ/Δ+ECE1Δ184–279) induced lower levels
of pEGFR Y1068 in tongue tissues as compared with wild-type
(WT) C. albicans infection (Fig. 1c, d). Collectively, these data
demonstrate that candidalysin activates the EGFR.
EGFR governs candidalysin-induced immune responses. To
establish whether EGFR drives candidalysin-induced intracellular
signalling and epithelial cell immune responses, we treated TR146
epithelial cells with the EGFR inhibitors Gefitinib or PD153035,
prior to C. albicans infection or candidalysin treatment. Both
inhibitors significantly suppressed WT C. albicans-induced pEGFR
(Y1068 and Y845), c-Fos, pMKP1 (Fig. 2a) and all cytokines
investigated (IL-1α, IL-1β, IL-6, GM-CSF and G-CSF) (Fig. 2b–f).
As a control, the ece1Δ/Δ+ECE1Δ184-279 candidalysin-deficient
strain was used to infect non-EGFR-inhibited cells and was
unable or poorly able to induce pEGFR, c-Fos, pMKP1 or cytokine
release. Additionally, Gefitinib and PD153035 significantly sup-
pressed candidalysin-induced pEGFR, c-Fos, pMKP1, GM-CSF and
G-CSF (Fig. 2g, k, l), though IL-1α and IL-6 release were elevated
while IL-1β release remained unchanged (Fig. 2h–j). Importantly,
EGFR inhibitors did not affect candidalysin-induced LDH release
(Supplementary Fig. 5a) suggesting that EGFR is not involved in the
membrane-permeabilising actions of candidalysin2; nor does either
inhibitor affect C. albicans hyphal growth (Supplementary Fig. 5b).
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The data indicate that EGFR activation is required for candidalysin-
induced MAPK signalling and release of GM-CSF and G-CSF
during C. albicans infection.
EGFR protects against C. albicans infection in zebrafish. To
assess EGFR function in vivo, we used an established and tractable
zebrafish swimbladder model of mucosal C. albicans infection that
has been shown to faithfully recapitulate events in complex
mammalian systems23–26. Immune-competent zebrafish larvae
swimbladders were inoculated with C. albicans prior to incubation
in E3-water containing AG1478 EGFR inhibitor. 70% of infected
fish treated with AG1478 inhibitor died within 72 h of fungal
inoculation, whereas all vehicle-treated (DMSO) controls survived
infection (Fig. 3a). Additionally, AG1478-treated fish exhibited a
four-fold reduction in neutrophil recruitment at sites of infection,
when compared to vehicle-treated animals (Fig. 3b, c), though
fungal burdens between the groups were similar (Fig. 3d). We next
investigated the effect of EGFR inhibition in a murine OPC model.
In immune-competent mice, however, oral administration of
EGFR inhibitor (Gefitinib, PD153035, AG1478 or GW2974),
induced a significant decrease in fungal burden within tongue
tissues at day 1 p.i. when compared with control animals (Sup-
plementary Fig 6). Thus, EGFR appears to promote murine oral
infection but, contrastingly, offers immune protection against C.
albicans infection in the zebrafish swimbladder model.
Candidalysin induces EGFR ligand release. To understand how
candidalysin activates EGFR, we investigated potential physical
interactions between these molecules. Confocal imaging of TR146
cells after treatment with an AlexaFluor-488-labelled candidalysin
and staining with Dy549-labelled EGFR affibody, revealed no co-
localisation (Fig. 3e). AlexaFluor-candidalysin was observed in the
cytoplasm at 2min post-treatment while EGFR remained at the cell
surface. At 30min, both candidalysin and EGFR were found in the
cytoplasm but with distinct, non-overlapping staining patterns.
Additionally, surface plasmon resonance (SPR) analysis confirmed
that candidalysin does not directly interact with extracellular,
transmembrane or cytoplasmic EGFR receptor portions (Fig. 3f).
We next explored indirect mechanisms of EGFR activation by
candidalysin. The ErbB family of receptors is activated by binding
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Fig. 1 Candidalysin (CL) activates EGFR. a Phosphorylation: Infection of TR146 cells with WT C. albicans induces EGFR phosphorylation at two distinct
tyrosine sites, Y1068 and Y845, while a strain lacking the candidalysin-encoding region (ece1Δ/Δ+ECE1Δ184–279) does not (left panel). Phosphorylation of
EGFR at both sites was also induced following direct candidalysin treatment in a dose-dependent manner (right panel). Data are representative of three
biological repeats. Protein lysates were taken at 2 h p.i. for western blot analysis. Solid vertical lines indicate omitted, extraneous portions of blot images.
b Internalisation: At 30min post CL treatment, EGFR is significantly internalised. Data collected from a total of 120,000 cells per group over three
independent experiments. Median value indicated, error bars represent min-max data points. Values are shown as a Log transformed ratio of EGFR staining
intensity inside the cell to the total cell intensity of EGFR staining. c Murine pEGFR staining: Immune compromised mice were infected with a C. albicans
ece1Δ/Δ mutant (lacking ECE1 which encodes the parent protein from which candidalysin is derived) and tongues were harvested at day 1 p.i. Paraffin-
embedded, 3 mm tissue sections were prepared and stained for pEGFR (Y1068). The ece1Δ/Δ mutant exhibits reduced capacity to phosphorylate EGFR
above a given threshold (threshold set using Image J software), when compared to WT C. albicans infections. Data from 9 (WT) and 11 (ece1Δ/Δ)
individual mice obtained over two independent experiments. d Murine pEGFR staining: Immune competent mice were infected with the candidalysin-
deficient ece1Δ/Δ+ECE1Δ184–279 mutant which also exhibited a reduced ability to phosphorylate EGFR at Y1068, when compared to WT infection.
Data obtained from one experiment, 5 mice per group. Unpaired T-tests were used to determine statistical significance in (b, c, d). Error bars from
(c, d) represent Standard deviation (SD). *p < 0.05, **p < 0.01
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to one or more of their 11 endogenous ligands: epidermal growth
factor (EGF), heparin-binding EGF (HB-EGF), TGF-α, amphir-
egulin (AREG), betacellulin (BTC), neuregulins (NRGs) 1-4,
epiregulin (EREG) and epigen (EPG). ErbB family ligands are
bound to the cell surface as inactive pro-ligand precursors which
can undergo cleavage to release functional ectodomains that
induce autocrine or paracrine signalling following ligation27. We
found that candidalysin potently induced EREG, EPG and NRG2-
4 shedding in a dose-dependent manner within 15 min post
treatment (Fig. 4a–e). AREG was also released but shedding was
gradual and accumulated over 6 h (Fig. 4f). Importantly,
candidalysin-deficient C. albicans strains (ece1Δ/Δ and ece1Δ/Δ
+ECE1Δ184–279 (grey bars)) were unable to induce EREG or EPG
shedding (Fig. 4g, h), and less able to induce AREG shedding
(Fig. 4i), when compared with candidalysin-expressing strains
(WT and ece1Δ/Δ+ECE1 (black bars)); NRG2-4 were not
detected following infection with any strain. Notably, EGF,
HB-EGF, TGF-α and BTC were not detectable following
candidalysin treatment or C. albicans infection at any time point.
Together, the data indicate that candidalysin induces shedding of
EREG, EPG and AREG from epithelial cells during C. albicans
infection.
EGFR ligands partially mimic candidalysin-induced responses.
We next investigated whether EGFR ligands directly mediated the
candidalysin-triggered response. EREG and EPG were selected for
use as exogenous stimuli based on their rapid induction by
candidalysin (Fig. 4a, b) and also by their lack of induction by
candidalysin-deficient C. albicans strains (Fig. 4g, h). We focused
our investigations on immediate early responses (within 2 h),
eliminating both AREG, which is not significantly released until
later time points, and NRGs, which are not released at all during
C. albicans infection, from further assessment. Dose-dependent
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phosphorylation of EGFR (Y1068 and Y845) and MKP1 was
observed following addition of EREG or a combination of EREG
and EPG (Fig. 4j), whereas EPG induced dose-dependent phos-
phorylation of EGFR Y1068 and MKP1 only. Induction of
pEGFR Y845 or c-Fos with either ligand was not as potent as that
observed with lytic doses of candidalysin (70 µM). Notably, nei-
ther EREG nor EPG were able to stimulate cytokine release
(Fig. 4k–o), though a small dose-dependent trend was observed
for EREG-induced IL-6, GM-CSF and G-CSF. Together, these
data indicate that EREG and EPG partially mimic candidalysin-
induced activation of EGFR signalling but not cytokine responses.
MMPs are required for candidalysin-induced immune
responses. Matrix metalloproteinases (MMPs) and A Disintegrin
and Metalloproteinase domain-containing proteins (ADAMs) are
two families of enzymes that cleave EGFR pro-ligands. We thus
investigated their involvement in activation of EGFR-MAPK
signalling in response to candidalysin. Pre-incubation of TR146
cells with the pan-MMP inhibitor Marimastat, but not the
ADAM10 inhibitor GI-253023X, suppressed pEGFR (Y1068 and
Y845), c-Fos and pMKP1 in candidalysin-treated cells (Fig. 5a).
However, neither Marimastat nor GI-253023X had a significant
effect on candidalysin-induced EREG or EPG shedding. (Fig. 5b,
c). Given the lack of effect when using the ADAM10 inhibitor,
further experimentation was continued with Marimastat only.
Marimastat had no suppressive effects on candidalysin-induced
IL-1α, IL-1β or IL-6 (Fig. 5d–f), but significantly reduced GM-
CSF and G-CSF secretion (Fig. 5g, h). In response to WT C.
albicans infection, Marimastat significantly suppressed pEGFR
(Y1068 and Y845), c-Fos and pMKP1 (Fig. 5i) as well as EREG,
EPG, IL-1α, IL-1β, GM-CSF and G-CSF, but not IL-6 (Fig. 5j–p).
The candidalysin-deficient C. albicans strain, ece1Δ/Δ
+ECE1Δ184–279, stimulated no or minimal responses (Fig. 5i–p),
again demonstrating the requirement of candidalysin for epi-
thelial cell activation during infection. C. albicans hyphal growth
and candidalysin-induced LDH release were unaffected by Mar-
imastat (Supplementary Fig. 7a, b). The data indicate that MMPs
are involved in candidalysin-triggered activation of epithelial cells
during C. albicans infection.
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Confocal point images have a 91.36 µmx 90.79 µm (left image) and 35.9 µmx 35.9 µm (right image) field of view. Images are representative of three individual
experiments. f Surface plasmon resonance response of candidalysin and EGFR domains : SPR signal response for the different domains of EGFR did not reach
above 50 RU when interacting with biotinylated-candidalysin (180 s injection of 500 nM of titrant at 10 µL/min flow, 25 °C). Approximate response expected
for binding of extracellular or cytoplasmic domains is 900 RU (dotted line) at a Kd of 20mM
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Calcium chelation inhibits candidalysin-induced responses.
Given that EREG and EPG did not account for candidalysin-
induced cytokine release, we investigated additional mechanisms
of EGFR-dependent immune activation. We have previously
shown that candidalysin induces calcium influx in epithelial cells2
and potassium efflux in macrophages28. We assessed the invol-
vement of these ions in candidalysin-triggered EGFR activation,
using the potassium channel blocker glibenclamide and the
intracellular calcium chelator Bapta-AM. Pre-treatment of TR146
cells with Bapta-AM, but not glibenclamide, significantly
suppressed candidalysin-induced (70 µM) pEGFR (Y1068 and
Y845), c-Fos and pMKP1 (Fig. 6a), IL-1α, IL-1β and G-CSF
(Fig. 6b, c, f), but not IL-6 or GM-CSF secretion, though a clear
trend in reduction was observed (Fig. 6d, e). Additionally, Bapta-
AM was able to suppress candidalysin-induced EREG and EPG
shedding (Fig. 6g, h). These observations were not made with
glibenclamide. Additionally, neither inhibitor affected damage
induction (Supplementary Fig. 8). These data indicate that cal-
cium influx may contribute to the EGFR-mediated epithelial
response to candidalysin.
e
ce
1Δ
/Δ
+
EC
E1
Δ 1
84
–2
79
0
*
**
0
**
**
****
a
0
*
**
*
**
*
**
0
**
**
0
5 **
***
***
***
0
* **
*
j
0
0
0
0
pEGFR Y1068
pEGFR Y845
C-Fos
pMKP1
a-actin
CL EP
G
 1
0
EP
G
 2
5
ER
EG
 2
5
EP
G
 5
0
ER
EG
 5
0
ER
EG
 1
0
Ligand (ng/mL)
H
2O
BS
A
EP
G
 +
ER
EG
 1
0
EP
G
 +
ER
EG
 2
5
***
***
***
***
***
Ep
ire
gu
lin
 (p
g/m
L)
5000
4000
3000
2000
1000
–1000
0
4000
3000
2000
1000
–1000
0
4000
3000
2000
1000
–1000
70 15 3 V 70 15 3 V 70 15 3 V 70 15 3 V 70 15 3 V
15 m 30 m 2 h 3 h 6 h
Candidalysin (μM)
70 15 3 V 70 15 3 V 70 15 3 V 70 15 3 V 70 15 3 V
15 m 30 m 2 h 3 h 6 h
Candidalysin (μM)
70 15 3 V 70 15 3 V 70 15 3 V 70 15 3 V 70 15 3 V
15 m 30 m 2 h 3 h 6 h
Candidalysin (μM)
70 15 3 V 70 15 3 V 70 15 3 V 70 15 3 V 70 15 3 V
15 m 30 m 2 h 3 h 6 h
Candidalysin (μM)
70 15 3 V 70 15 3 V 70 15 3 V 70 15 3 V 70 15 3 V
15 m 30 m 2 h 3 h 6 h
Candidalysin (μM)
70 15 3 V 70 15 3 V 70 15 3 V 70 15 3 V 70 15 3 V
15 m 30 m 2 h 3 h 6 h
Candidalysin (μM)
Ep
ig
en
 (n
g/m
L)
15
10
N
eu
re
gu
lin
 2
 (p
g/m
L)
N
eu
re
gu
lin
 3
 (p
g/m
L)
**
******
***
*** ***
***
***
2500
2000
1500
1000
500
0
2500
2000
1500
1000
500
–500
N
eu
re
gu
lin
 4
 (p
g/m
L)
Am
ph
ire
gu
lin
(pg
/m
L)
***
b
c
d
e
f
Ep
ire
gu
lin
 (p
g/m
L)
5000
4000
3000
2000
1000
BW
P1
7
e
ce
1Δ
/Δ
e
ce
1Δ
/Δ
+
EC
E1
e
ce
1Δ
/Δ
e
ce
1Δ
/Δ
+
EC
E1
PB
S
e
ce
1Δ
/Δ
+
EC
E1
Δ 1
84
–2
79
PB
S
Ep
ig
en
 (n
g/m
L)
300
200
100
BW
P1
7
e
ce
1Δ
/Δ
e
ce
1Δ
/Δ
+
EC
E1
e
ce
1 Δ
/Δ
+
EC
E1
Δ 1
84
–2
79
PB
S
BW
P1
7
Am
ph
ire
gu
lin
 (p
g/m
L) 1500
1000
500
IL
-1
α
 
(ng
/m
l)
2.5
2.0
1.5
1.0
0.5
0.0
CL
EP
G
 1
0
EP
G
 2
5
BS
A
H
2O
EP
G
 +
 E
RE
G
 2
5
EP
G
 +
 E
RE
G
 1
0
ER
EG
 5
0
ER
EG
 2
5
ER
EG
 1
0
EP
G
 5
0
CL
EP
G
 1
0
EP
G
 2
5
BS
A
H
2O
EP
G
 +
 E
RE
G
 2
5
EP
G
 +
 E
RE
G
 1
0
ER
EG
 5
0
ER
EG
 2
5
ER
EG
 1
0
EP
G
 5
0
CL
EP
G
 1
0
EP
G
 2
5
BS
A
H
2O
EP
G
 +
 E
RE
G
 2
5
EP
G
 +
 E
RE
G
 1
0
ER
EG
 5
0
ER
EG
 2
5
ER
EG
 1
0
EP
G
 5
0
CL
EP
G
 1
0
EP
G
 2
5
BS
A
H
2O
EP
G
 +
 E
RE
G
 2
5
EP
G
 +
 E
RE
G
 1
0
ER
EG
 5
0
ER
EG
 2
5
ER
EG
 1
0
EP
G
 5
0
CL
EP
G
 1
0
EP
G
 2
5
BS
A
H
2O
EP
G
 +
 E
RE
G
 2
5
EP
G
 +
 E
RE
G
 1
0
ER
EG
 5
0
ER
EG
 2
5
ER
EG
 1
0
EP
G
 5
0
IL
-1
β 
(pg
/m
L)
250
200
150
100
50
G
M
-C
SF
 (p
g/m
L) 250
200
150
100
50
IL
-6
 (p
g/m
L)
15,000
10,000
5000
G
-C
SF
 (p
g/m
L)
4000
3000
2000
1000
g
h
i
k
l
m
o
n
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-09915-2
6 NATURE COMMUNICATIONS |         (2019) 10:2297 | https://doi.org/10.1038/s41467-019-09915-2 | www.nature.com/naturecommunications
Discussion
Candidalysin, discovered in 2016, is the first cytolytic peptide
toxin identified in any human fungal pathogen2. Candidalysin is
immunostimulatory and critical for cytokine induction at the
epithelium during C. albicans infection, which occurs via MAPK
signalling2,4,10,21. However, the receptor-mediated mechanism by
which activation occurs was hitherto unknown. Here, we
demonstrate that EGFR activation is critical for candidalysin-
induced MAPK signalling and neutrophil recruitment,
which involves release of EGFR ligands and calcium influx.
Thus, we identify the first PAMP-independent sensor circuit that
activates immune responses against any human fungal pathogen.
EGFR is targeted by bacterial, viral and fungal species that
exploit this receptor and its wide array of functions for replicative
benefit29–35. However, beneficial host functions can also be pro-
moted through EGFR activation16–19. Interestingly, there is also
evidence of both mechanisms being present during infection,
likely reflecting pathogen exploitation and host protective func-
tions occurring in parallel. One example is EGFR activation by
Staphylococcus aureus, which drives cleavage of epithelial junction
proteins to facilitate barrier transmigration, but also induces
protection against S. aureus infection36–38 via secretion of IL-1α
and IL-1β39. Such opposing EGFR actions may also exist during
C. albicans infection, where the EGFR/Her2 heterodimer has been
reported as a co-receptor, binding fungal agglutinin-like sequence
3 (Als3) to aid internalisation and infection40. We now report an
additional role for EGFR in protection against C. albicans
pathogenicity and identify this receptor as a critical component of
candidalysin-induced immune responses. This dual function of
EGFR is supported by three lines of evidence from previous work
showing that (i) Als3p strongly promotes fungal adhesion but
does not induce MAPK (c-Fos/pMKP1) signalling or cytokine
induction in oral epithelial cells41, (ii) an ece1Δ/Δ mutant is
internalised but unable to induce MAPK (c-Fos/pMKP1) sig-
nalling or cytokine induction2, and (iii) C. albicans induces a
strong pro-inflammatory response with accompanying protective
neutrophil recruitment in a candidalysin-dependent manner in
immune competent mice4,5,10. With these observations in mind,
the contrasting data obtained from our in vivo models appear to
demonstrate the two distinct EGFR functions. EGFR inhibition in
mice results in reduced fungal load and no adverse effects fol-
lowing infection, which likely reflect the documented co-receptor
functions of EGFR40. In zebrafish, however, EGFR activity pre-
vents mortality and promotes neutrophil recruitment, supporting
a protective and immunostimulatory role for EGFR. A suggested
explanation for these distinct observations may be provided by
considering the differing environments within either model. The
murine oral cavity is subject to constant disruption during eating,
drinking and grooming, rendering C. albicans heavily reliant on
efficient and functional host receptors for successful infection.
The swimbladder air-sac, however, provides an enclosed,
undisturbed space and thus comparatively greater opportunity for
fungal attachment, such that a reduction in EGFR activity may
not abrogate internalisation. In this model, other receptors known
to mediate C. albicans endocytosis, such as E-cadherin19,20, N-
cadherin21 and EphA222, may be sufficient in compensating in
the absence of EGFR function, thus allowing for subsequent
infection of tissues to provide a functional model for investigation
of C. albicans-induced immune responses.
Interestingly, the observed reduction in neutrophil recruitment
and subsequent mortality within EGFR-inhibited fish is not
associated with an increase in fungal burden. Nor is it due to any
toxic effects of the inhibitor, as we show that there is no mortality
upon treatment of AG1478 alone. The literature surrounding
neutrophil functions has historically focused on direct pathogen
killing mechanisms. However, an emerging role for neutrophils in
resolving the effects of infection, particularly inflammation, is
being uncovered. Reports include stimulation of anti-
inflammatory cytokines as well as wound healing and repair
functions42–45. Notably, the IL-17 receptor (IL-17R), a potent
regulator of neutrophil activation and antifungal immunity, has
been shown to promote wound healing via EGFR recruitment46.
Our data may thus be supportive of such functions, where a lack
of inflammatory policing by neutrophils rather than over-
whelming fungal burden, may explain the mortality observed in
EGFR-inhibited zebrafish.
Interestingly, we show that candidalysin is able to induce both
cellular damage and protective functions within the infected host.
The factors that may tip the balance between disease and
restoration of health in the context of C. albicans infection is
intriguing and likely complex and multifactorial in nature.
Greater understanding in this area will undoubtedly provide new
avenues to improve current therapies against this pathogenic
fungus.
The importance of EGFR in mediating candidalysin-induced
immune responses was observed through several approaches
using EGFR-inhibition, which resulted in significant loss of
MAPK signalling, neutrophil activating cytokines and subsequent
neutrophil recruitment into infected tissues. Additionally, we
found candidalysin to be largely responsible for the shedding of
several ErbB ligands during infection, all of which ligate EGFR.
Interestingly, while the classical ErbB ligands such as EGF and
TGF-α were not shed, candidalysin did induce shedding of EREG,
EPG, AREG and NRG2,3 and 4, relatively recent ligand-family
members to be identified and consequently less understood47–49.
This is the first reported association between EGFR ligands and
fungal infection, with epigen not previously being associated with
any microbial infection.
While EREG and EPG contribute to candidalysin-triggered
signalling, they were weak inducers of c-Fos and cytokines.
Calcium flux, however, was important for initiating EGFR-
mediated immune responses, with calcium chelation resulting
Fig. 4 Candidalysin-induced release of EREG and EPG contribute to subsequent EGFR-mediated signalling. Release of EREG (a), EPG (b) and NRGs 2, 3 and
4 (c–e) was observed following treatment of candidalysin to TR146 cells, in a dose-dependent manner with rapid onset (within 15 min). AREG was also
detected in candidalysin-treated cell supernatants, but the release was gradual and accumulated over 6 h (f). At 24 h p.i. epiregulin (EREG) (g) and epigen
(EPG) (h) were induced by candidalysin-expressing (WT and ece1Δ/Δ+ECE1 (black bars)) but not candidalysin-deficient (ece1Δ/Δ and ece1Δ/Δ
+ECE1Δ184–279 (grey bars)) C. albicans strains. While amphiregulin (AREG) was induced by all fungal strains tested, diminished potency was observed by
those unable to express candidalysin (i). Increasing concentrations of EREG, EPG or EREG+ EPG, were used to stimulate TR146 oral epithelial cells.
j Phosphorylation of EGFR (at Y1068 and Y845 sites) and MKP1 proteins occurred in a dose-dependent manner in response to EREG and EREG+ EPG, but
not EPG alone. Induction of c-Fos by ligand stimulation was not dose-dependent (j). The effects of ligand exposure are not comparable to that of 70 µM
candidalysin. While a dose-dependent trend of IL-6 (m), GM-CSF (n) and G-CSF (o) induction is observed in response to increasing concentrations of all
ligand combinations, the changes are not statistically significant. IL-1α (k) and IL-1β (l) are not induced by ligand exposure. One-way ANOVA followed by a
Bonferroni multiple comparison’s test was used to calculate statistical significance between groups. Graphs are an average of 3 (a–g, i–o) or 2 (h)
independent experiments; one-way ANOVA with Bonferroni multiple comparison’s test used to assess statistical significance between samples from the
same timepoint. Error bars represent SD. *p < 0.05, **p < 0.01, ***p < 0.001
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in impaired EREG/EPG shedding, MAPK signalling and cyto-
kine release in response to candidalysin. While calcium is not
known to directly ligate EGFR, its ability to activate the EGFR
has been documented, resulting in MAPK signalling and EGFR
internalisation50,51. In light of our findings, we propose that
pore-formation and calcium flux occur upstream of EGFR and
are the critical first steps in epithelial activation by
candidalysin.
The dependence of GM-CSF and G-CSF release on EGFR
signalling was consistently observed, with significant impairment
of release in the presence of EGFR or MMP inhibition. GM-CSF
and G-CSF possess potent functions in neutrophil activation and
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Fig. 5 MMP inhibition suppresses the candidalysin and C. albicans-induced response pathway. Pre-treatment of TR146 cells with Marimastat (MMP
inhibitor, 10 µM) but not GI-253023X (ADAM10 inhibitor, 5 µM), significantly suppressed candidalysin-induced expression of pEGFR (Y1068 and Y845),
c-Fos and pMKP1 (a). MMP inhibition had no suppressive effects on candidalysin-induced EREG (b) EPG (c), IL-1α (d), IL-1β (e) or IL-6 (f) but did suppress
GM-CSF (g) and G-CSF (h) cytokine release. In Marimastat-inhibited, WT C. albicans-infected cells, significant suppression of all investigated proteins
(i–o) except IL-6 (p), was observed. The candidalysin-deficient ece1Δ/Δ+ECE1Δ184–279 strain also failed to induce phosphorylation of EGFR or MKP1, c-Fos
expression (i) or our panel of cytokines (l–p). Protein lysates were taken at 2 h post infection for western blot analysis, cytokines assessed at 24 h post
infection via luminex. Solid vertical lines indicate omitted, extraneous portions of blot images. Unmatched, one-way ANOVA with Bonferroni multiple
comparison’s test used to assess statistical significance. All images and graphs are representative of three independent experiments. One-way ANOVA
with Bonferroni multiple comparison’s test was used to assess statistical significance. Error bars represent SD. *p < 0.05, **p < 0.01, ***p < 0.001
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chemotaxis which are necessary for successful resolution of C.
albicans infections52–57. These data support our previous studies
highlighting the requirement of candidalysin in neutrophil
recruitment during C. albicans infection2,4,10.
In light of our findings, we propose that there exists a
candidalysin-triggered pathway of EGFR activation and epi-
thelial immune induction during invasive C. albicans infection.
Calcium influx is induced by candidalysin-mediated membrane
permeabilisation2 and is also a process known to induce MMP
activation and expression58–60. We propose that cleavage of
EGFR ligands by MMPs, together with increased intracellular
calcium levels may function to activate EGFR, resulting in EGFR
phosphorylation/internalisation and activation of MAPK sig-
nalling, driving release of neutrophil chemokines. This scenario
will likely take place during hyphal growth in the invasion
pocket2,61, where high concentrations of candidalysin may
accumulate (and synergise with other fungal factors10), thereby
reaching the threshold level required for full epithelial activa-
tion. Subsequent release of cytokines induce downstream innate
immune responses, including neutrophil recruitment, critical for
protection against mucosal candidiasis2,4,10,11.
In summary, we identify EGFR as a promoter of protective
responses during C. albicans infection and highlight candidalysin
and EGFR signalling components as potential targets for ther-
apeutic intervention against mucosal candidiasis.
Methods
Cell culture. In vitro experiments were carried out using the TR146 human buccal
epithelial squamous cell carcinoma cell line62, obtained from European Collection
of Authenticated Cell Cultures (ECACC) and cultured in Dulbecco’s Modified
Eagle’s Medium (DMEM, Sigma-Aldrich), supplemented with 10% foetal bovine
serum (FBS) and 1% penicillin-streptomycin. Serum-free DMEM was used to
replace normal growth medium 24 h before and during the experimentation
process.
Reagents. The EGFR kinase domain inhibitors were purchased from Santa Cruz
(Gefitinib), Selleckchem (PD153035), Tocris Bioscience (AG1478) and Sigma
(GW2974). Marimastat, GI-253023X, glibenclamide and Bapta-AM were pur-
chased from Tocris Bioscience. Inhibitors were reconstituted in DMSO and ali-
quoted for appropriate freezer temperature storage. TR146 cells were incubated
with inhibitors for 1 h prior to C. albicans infection, candidalysin exposure or mock
treatment. Phospho-EGFR Tyr1068 (#3777), phospho-EGFR Tyr845 (#6963S), c-
Fos (#2250S) and phospho-MKP1 (#2857S) antibodies were purchased from Cell
Signalling Technology. Mouse anti-human α-actin antibody was purchased from
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Fig. 6 Calcium is required for candidalysin-triggered immune responses and lies upstream of EGFR. Pre-treatment of TR146 cells with a calcium chelator (Bapta-
AM 30 µM) reduced levels of pEGFR Y1068 and Y845, c-Fos, pMKP1 (a), IL-1α (b), IL-1β (c), G-CSF (f), EREG (g) and EPG (h), following candidalysin exposure.
This is not observed when using the potassium inhibitor glibenclamide (30 µM). IL-6 (d) and GM-CSF (e) are not significantly suppressed by either inhibitor,
though a reduction is observed. Protein lysates were taken at 2 h post infection for western blot analysis, cytokines assessed at 24 h post infection via luminex.
Unmatched, one-way ANOVA with Bonferroni multiple comparison’s test was used to assess statistical significance. Images and graphs are representative of 2
(a, g, h) or 3 (b–f) independent experiments, respectively. Error bars represent SD. *p < 0.05, **p < 0.01, ***p < 0.001, n.s. p > 0.05
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Millipore (UK) (#MAB1501), goat anti-mouse (#115-035-062) and anti-rabbit
(#111-035-144) horseradish peroxidase (HRP)-conjugated antibodies were pur-
chased from Jackson Immunologicals (Stratech Scientific, UK). Fluorescent ErbB
receptor affibodies were a kind gift from the Science and Technologies Facilities
Council for use with confocal imaging work. APC anti-human EGFR antibody was
purchased from BioLegend (# 352905) for use with Imagestream analyses. Biolo-
gically active EREG and EPG were purchased from Peprotech and used at 10, 25
and 50 ng/mL either individually or together at the same concentration.
Candidalysin. Candidalysin (SIIGIIMGILGNIPQVIQIIMSIVKAFKGNK) was
synthesised by Proteogenix (France) or Peptide Protein Research Ltd (UK), and
reconstituted in sterile purified water to 10 mg/mL for storage, prior to further
dilution for individual experiments. Alexa-488 conjugated candidalysin (C(AF488)
SIIGIIMGILGNIPQVIQIIMSIVKAFKGNK), was used for confocal imaging.
Candida strains. The auxotrophic BWP17+CIp3063 wild type (WT) C. albicans
strain, ece1Δ/Δ (ece1 null), ece1Δ/Δ+ECE1 and ece1Δ/Δ+ECE1Δ184–279, C. albicans
strains were used in this study (see ref. 2 for full descriptions). CAF2-dTomato C.
albicans strain was used for zebrafish experiments24. YPD medium (1% yeast
extract, 2% peptone, 2% dextrose in water) was used to culture C. albicans fungi
overnight in a non-airtight container, shaking at 200 rpm at 30 °C. Cultures were
washed in PBS prior to dilution in the appropriate media for experimentation at
the correct fungal cell density. A multiplicity of infection (MOI) of 10 was used for
2 h in vitro experiments, and MOI of 0.01 for 24 h experiments, while 1 × 107
fungal cells/mL of C. albicans was used for murine inoculation and 15–25 fungal
cells inoculated per fish swimbladder.
ELISA. Following experimentation, culture supernatants were collected and ali-
quoted before storage at −80 °C for subsequent use. ELISA kits were purchased
from R&D Systems (Amphiregulin, Duoset kit), ELabscience (Epiregulin, Neur-
egulin 2, 3, 4) and CusaBio (Epigen) and performed following the manufacturer’s
instructions. Briefly, target proteins were bound to 96-well plates pre-coated with
capture antibody. Biotinylated detection antibody was then applied to wells, fol-
lowed by addition of a streptavidin-HRP complex. A substrate solution was then
added and the absorbance of samples measured using a spectrophotometer at a
wavelength of ~450 nm. Wash steps were performed three times between each
stage of reagent addition.
Western blotting. RIPA lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1
mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS) containing
protease (Sigma-Aldrich) and phosphatase (Perbio Science) inhibitors was used to
lyse cells following experimentation. Lysates were left on ice for 30 min then
centrifuged at 4 °C to remove debris before −80 °C storage. The concentration of
protein was determined using a BCA protein quantitation kit (Perbio Science) and
10 µg of whole protein extract was separated on 12% acrylamide SDS-PAGE gels
before transferring to nitrocellulose membranes (GE Healthcare). Membranes were
probed for target proteins with primary (1:1000) for all proteins except c-Fos
(1:3000) and secondary (1:10,000) antibodies before being developed using
Immobilon chemiluminescent substrate (Millipore) and exposure to X-ray film
(Fiji film). Human α-actin was used as a loading control.
Cytokine secretion. A performance magnetic fluorokine MAP cytokine multiplex
kit (Bio-techne) and a Bioplex-200 machine (Bio-Rad) were used to quantify the
level of cytokine secretion in culture supernatants. Anti-IL-1α, IL-1β, IL-6, GM-
CSF and G-CSF antibody beads were purchased from Bio-techne. Bioplex manager
6.1 software was used to determine analyte concentrations.
Cell damage (LDH) assay. A Cytox 96 Non-Radioactive Cytotoxicity Assay kit
(Promega) was used to measure the activity of lactate dehydrogenase (LDH) in
collected culture supernatant samples. The manufacturer’s instructions were fol-
lowed and recombinant porcine LDH (Sigma-Aldrich) was used to generate a
standard curve. Samples were measured for LDH immediately after collection from
culture plates.
IHC staining and quantification. IHC was performed using the avidin/biotin
staining method with the Vector stain elite kit (Vector labs). Formalin fixed
paraffin-embedded tissue sections (5 µm) were sectioned and mounted on super-
frost plus slides. Antigen retrieval was carried out with a microwave pressure
cooker and citric acid buffer (pH 6.4) was pre heated to boiling. Slides were
microwaved for 5 min under pressure and stained for pEGFR Y1068 with Rabbit
monoclonal antibody ab40815 (Abcam) at a 1:10,000 dilution. Staining with buffer
solution instead of primary antibody was used as a negative control.
Images at ×20 magnification were taken to cover the entire length of the
epithelium for a given tissue section, resulting in multiple images per animal
tongue. Image J software was then used to calculate the percentage staining in each
image. The pixel area was first determined by drawing around the epithelium from
the surface to basement membrane. Calculation of staining intensity above a given
threshold was then determined using the colour-threshold tool, using set
boundaries for hue (0–127) and saturation (100–255). The total area covered by
pixels within this range of colour intensity was then determined and displayed as a
percentage of total epithelium area. An average percentage for all images of each
tongue was then used for graphical representation.
Confocal imaging. TR146 cells were stained with DAPI and 100 nM anti-EGFR
affibody-Dy549 prior to candidalysin-Alexa 488 stimulation (15 µM), and fixed
with 4% formaldehyde before imaging with a Leica SP8 confocal microscope
equipped with a 1.4 NA oil immersion objective. PBS was used as the imaging
buffer. Leica HyD hybrid detectors operating in standard mode with a gain factor
of 100 were used to acquire 1024 × 1024 images of a 116.74 × 116.74 µm field of
view. DAPI fluorescence was excited at 405 nm and detected between 420 and 520
nm. Alexa 488 was excited at 488 nm and detected between 505 and 560 nm. Dy549
was excited at 561 nm and detected between 570 and 625 nm. The confocal images
for each fluorescent probe were acquired sequentially. Leica Application Suite X
software was used to view images.
For imaging infected zebrafish swimbladders, fish were anaesthetized with
Tricaine then immobilized in 0.5% low-melting-point agarose (Lonza) in E3
containing Tricaine and arranged in a 96-well glass-bottom imaging plate (Mattek,
Ashland, MA). Images were acquired on an Olympus IX-81 inverted microscope
with an FV-1000 laser scanning confocal system (Olympus, Waltham, MA), using
a ×20/0.7 NA or ×10/0.4 NA objective lens. EGFR and dTomato fluorescent
proteins were detected by laser/optical filters for excitation/emission at 488 nm/
505–525 nm and 543 nm/560–620 nm, respectively. Images were collected with
Fluoview (Olympus) software.
Imagestream. TR146 cells were treated with 15 µM candidalysin for 30 min, prior
to trypsin detachment from culture plates, fixed, then stained with fluorescently
labelled EGFR-APC antibody (BioLegend #352905 used at 5 µg/mL) in the pre-
sence of a permeabilising solution (BD fix/perm kit) according to the manu-
facturers’ instructions. Cells were washed using kit solutions and resuspended to
100 µL. An Imagestream MKII analyser (Merck) and IDEAS 6.2 software were used
to measure antibody fluorescence and quantify internalisation respectively. A total
of 40,000 cells per sample were acquired at ×40 magnification. Data were analysed
with IDEAS 6.2 using the Internalisation feature. The inside of each cell was
defined using the default mask on (BF, channel 9) eroded by 4 pixels. The inter-
nalisation feature is defined as the ratio of the intensity inside the cell to the
intensity of the entire cell. The higher the score, the greater the signal intensity
within the cell.
Surface plasmon resonance (SPR). All experiments were performed on a Biacore
T100 instrument (GE Healthcare) in HBS-EP Buffer (10 mM HEPES pH 7.4, 150
mM NaCl, 3 mM EDTA and 0.005% Surfactant P20, GE Healthcare). A specific
binding surface was prepared by coupling neutravidin to flow cells 2 and 3 of a
CM5 sensor chip (GE Healthcare) to a level of 800 resonance units (RU) through
amine coupling. N-term biotinylated candidalysin was loaded on flow cell 2 (to
capture densities up to 1000 RU). A 300 s injection with PEG-biotin was performed
to block remaining free neutravidin-binding sites. A biotinylated-candidalysin and
PEG-biotin functionalised chip was equilibrated in HBS-EP buffer until baseline
stability was observed. The different domains of EGFR (at different concentrations:
250, 500, 1000 and 2000 nM) were injected at 10 µL/min with a 100 s association
phase followed by a 600 s dissociation phase. Injections over sensor surfaces with
neutravidin only in flow cell 3 were performed to test unspecific binding. Both
EGFR extracellular and kinase domains showed unspecific binding at injections
>500 nM due to protein aggregation. Three independent runs were used for each
condition where changes in the resonance signal at both, the association and
dissociation steps, was followed.
Murine oropharyngeal candidiasis model. Murine infections were performed
under UK Home Office Project License PPL 70/7598 in dedicated animal facilities
at King's College London. No statistical method was used to pre-determine sample
size. No method of randomisation was used to allocate animals to experimental
groups. Mice in the same cage were part of the same treatment. The investigators
were not blinded during outcome assessment. A previously described murine
model of oropharyngeal candidiasis using female Balb/c mice (22–25 g)36 was
modified for investigating early infection events. Briefly, mice were treated sub-
cutaneously with 3 mg/mouse of cortisone acetate (in 200 µl PBS with 0.5% Tween
80) on days −1 and 1 p. i. On day 0, mice were sedated for 75 min with an
intraperitoneal injection of 110 mg/kg ketamine and 8 mg/kg xylazine, and a swab
soaked in a 107 cfu/ml C. albicans yeast culture in sterile saline was placed sub-
lingually for 75 min. After 1 day, mice were sacrificed, the tongue excised and
processed for immunohistochemistry. For EGFR inhibition studies, immune
competent female Balb/c mice were administered Gefitinib, PD153035, AG1478 or
GW2974 inhibitors at 100 mg/kg, 30 mg/kg, 20 mg/kg and 30 mg/kg respectively,
each day, via an oral dose of Nutella starting at day −2 with respect to C. albicans
infection (day 0). Appropriate volumes of inhibitor were mixed with 60 mg Nutella
and placed into a feeding well for each individually-housed mouse. Mice were
infected with 1 × 107 cfu/mL of Candida as above, euthanised and tongues were
excised on day 1 p.i. for fungal load assessment.
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Zebrafish swimbladder model. Cohorts of mpx:GFP zebrafish larvae were
infected with 15–25 CAF2-dTomato C. albicans yeast at 4 days post fertilization
(dpf) in the swimbladder, screened for accurate inoculum level, then incubated
either with DMSO or AG1478 (3 µM) in E3 water+ 0.02 mg/mL of 1-phenyl-2-
thiourea (PTU) (Sigma-Aldrich) to prevent pigmentation, until imaging by con-
focal microscopy at 24 h. For Mock, Mock+AG1478, C. albicans and C. albicans
+AG1478 groups, we used 5, 4, 10 and 10 zebrafish, respectively. The number of
neutrophils in the swimbladder lumen was counted from confocal z-stacks and the
median and interquartile range was plotted. Candida burden was quantified by the
number of red fluorescent pixels in the swimbladder, normalized to the area of the
swimbladder. Median and interquartile range were plotted. Confocal images were
taken at 24 h p.i. Neutrophils beyond the swimbladder boarders (outlined in
purple) were not included in analyses. Cohorts of wild-type AB larvae were infected
and screened as described above, then monitored for survival without imaging for
4 days p.i.
Microarray analysis. Reconstituted human oral epithelia (ROE: 5-day) created
using the TR146 cell line were purchased from SkinEthic Laboratories (France) and
used as previously described21. RNA was isolated from three independent ROE
infected with C. albicans SC5314 or an equal volume of PBS for 6 h using the
GenElute total mammalian RNA miniprep kit (Sigma, UK) and trace genomic
DNA removed using the Turbo DNase-free kit (Ambion, UK). For microarray
analysis, RNA was amplified using the MessageAmp Premier RNA Amplification
Kit (Ambion, UK) and hybridized onto U133a 2.0 gene chips (Affymetrix, UK)
according to standard protocols. Chips were scanned (Affymetrix GeneChip
Scanner 3000) and assessed using the Affymetrix Command Console (AGCC)
software suite. These data were statistically analysed using the Partek Genomics
Suite. Genes were considered to be differentially up- or downregulated when their
expression was changed by at least 2-fold with an FDR-adjusted P-value of less
than 0.01. Gene ontology and functional annotation clustering were performed on
the generated gene list using the web-based DAVID functional annotation tool
https://david.ncifcrf.gov64.
EGFR mutation assay. Genomic DNA was isolated from TR146 cells using the
GenElute™ Mammalian Genomic DNA Miniprep Kit (Sigma) according to the
manufacturer’s instructions. The DNA quantity and quality were evaluated with a
NanoDrop 2000 spectrophotometer. 59 different EGFR point mutations were
assessed using mutant-specific primers for Real-Time PCR (EGFR-RT52; Entrogen,
Inc). DNA samples were diluted to 10 ng/μL using PCR grade RNase/DNase free
water and heat-cycles were generated on a RotorGene 6000 (Qiagen). Amplifica-
tion curves were evaluated according to the manufacturer’s instructions.
Statistics. One-way analysis of variance (ANOVA) was used for all protein
secretion assays (LDH, cytokines, ErbB ligands) to calculate statistical significance
and corrected for multiple comparisons using the Bonferroni correction. Zebrafish
data were analysed using Kruskal Wallis with Dunn’s post-test correction, Mann-
Whitney and Log-rank with a Bonferroni correction. Murine in vivo data was
analysed using Mann-Whitney analysis. A p-value of less than 0.05 was taken to be
significant and represented as *, while < 0.01= ** and < 0.001= ***.
Ethical regulations for animal testing have been complied with and approved by
either St Thomas’ Hospital and Franklin Wilkins Building Animal Welfare and
Review Body (murine studies) or under the NIH Institutional Animal Care and Use
Committee, protocol A2015-11-03 (zebrafish studies).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Transcription array datasets of C. albicans-infected TR146 cells are available in the
ArrayExpress (EBI suite) repository, https://www.ebi.ac.uk/arrayexpress/experiments/E-
MTAB-7681. All supplementary data indicated within the manuscript, as well as
uncropped and unprocessed blots can be found in Supplementary Files.
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